Survival Outcomes of Limited-Stage Diffuse Large B-Cell Lymphoma Treated With Radiation Therapy

CONCLUSION: Though there is no consensus on optimal treatment indications for RT in LS-DLBCL, these data suggest certain subgroups may have benefit when RT is added to front-line chemotherapy.PMID:38000981 | DOI:10.1016/j.clml.2023.09.006

Source: Clinical Lymphoma and Myeloma - November 24, 2023 Category: Cancer & Oncology Authors: Daniel A Ermann Victoria A Vardell Harsh Shah Lindsey Fitzgerald Randa Tao David K Gaffney Deborah M Stephens Boyu Hu Source Type: research